Free Trial
NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

Enhabit logo
$7.35 -0.09 (-1.21%)
(As of 11/15/2024 ET)

About Enhabit Stock (NYSE:EHAB)

Key Stats

Today's Range
$7.27
$7.52
50-Day Range
$6.89
$8.24
52-Week Range
$6.85
$11.74
Volume
419,503 shs
Average Volume
583,356 shs
Market Capitalization
$369.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.35
Consensus Rating
Reduce

Company Overview

Enhabit, Inc. is a leading healthcare provider that offers Medicare-certified skilled home health and hospice services in the United States. The company operates in two segments: Home Health and Hospice, providing services to adult patients needing care, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Enhabit's hospice services include in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and emotional and spiritual support.

Enhabit operates home health agencies in approximately 34 states, with a concentration in the southern half of the United States. As of March 31, 2022, Enhabit operates in 252 home health agencies and 99 hospice agencies across 34 states. Enhabit provides practices to treat chronic diseases and conditions, including diabetes, arthritis, hypertension,  Alzheimer's disease, spinal stenosis, low vision,  Parkinson's disease, complex wound care, osteoporosis, and chronic pain, along with disease-specific plans for patients with diabetes, post-orthopedic surgery or injury, congestive heart failure,  and respiratory diseases.

Enhabit started as HealthSouth, founded in 1984 by Beam Scrushy and Richard Scrushy. In the early 2000s, the company restructured and rebranded into Encompass Health after being caught up in an accounting scandal. In Q2 of 2022, Enhabit, the healthcare and hospice division, became an independent public company, having completed its spinoff from Encompass Health Corporation. 

Barb Jacobsmeyer was named President and CEO of Enhabit Home Health & Hospice in June 2021. Jacobsmeyer came to Enhabit from Encompass Health, where she served as the company's executive vice president of operations. 

In Q3 of 2022, Enhabit, Inc. announced the acquisition of Caring Hearts Hospice, a locally-owned hospice agency in Texas. The acquisition adds four hospice locations in Texas to Enhabit's existing presence in the state. Ehnabit continues to expand, setting aside approximately one hundred million dollars to fund future mergers and acquisitions. 

Enhabit, Inc. is committed to providing high-quality care and service to patients and their families, and its success is a testament to its dedicated team of healthcare professionals. Enhabit is well-positioned to meet the growing demand for healthcare services in the United States as a leading home health and hospice service provider. With its focus on patient care and commitment to excellence, Enhabit is poised to continue to grow and succeed in the years ahead.

Enhabit's commitment to quality care has not gone unnoticed, as they have received numerous awards and recognitions for their services. In 2021, they were named a HomeCare Elite Top Agency for the 15th year. This recognition is given to the top-performing home health agencies in the United States. They have also received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for their home health services, indicating their high quality and patient satisfaction.

Enhabit's success can be attributed to its skilled and compassionate staff and dedication to providing comprehensive and individualized patient care. Enhabit also recognizes the importance of emotional and spiritual support for their patients and their families, particularly in hospice care. Their hospice services include pain and symptom management, spiritual counseling, palliative and dietary counseling, social worker visits, and bereavement counseling services to meet terminally ill patients and their families' individual physical, spiritual, emotional, and psychosocial needs.

Enhabit Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
75th Percentile Overall Score

EHAB MarketRank™: 

Enhabit scored higher than 75% of companies evaluated by MarketBeat, and ranked 288th out of 970 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Enhabit has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Enhabit has received no research coverage in the past 90 days.

  • Read more about Enhabit's stock forecast and price target.
  • Earnings Growth

    Earnings for Enhabit are expected to grow by 8.00% in the coming year, from $0.25 to $0.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Enhabit is -3.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Enhabit is -3.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Enhabit has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Enhabit's valuation and earnings.
  • Percentage of Shares Shorted

    3.05% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently decreased by 20.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Enhabit does not currently pay a dividend.

  • Dividend Growth

    Enhabit does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.05% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently decreased by 20.24%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Enhabit has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Enhabit this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Enhabit to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Enhabit insiders have bought more of their company's stock than they have sold. Specifically, they have bought $40,050.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.90% of the stock of Enhabit is held by insiders.

  • Read more about Enhabit's insider trading history.
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

EHAB Stock News Headlines

Jeffrey Bolton Bought 13% More Shares In Enhabit
Oppenheimer Keeps Their Hold Rating on Enhabit, Inc (EHAB)
The only candlestick pattern worth a darn
It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…
Enhabit, Inc. (EHAB) Q3 2024 Earnings Call Transcript
Enhabit names new CFO
See More Headlines

EHAB Stock Analysis - Frequently Asked Questions

Enhabit's stock was trading at $10.35 at the beginning of the year. Since then, EHAB shares have decreased by 29.0% and is now trading at $7.35.
View the best growth stocks for 2024 here
.

Enhabit, Inc. (NYSE:EHAB) issued its quarterly earnings data on Wednesday, November, 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.01. The business earned $253.60 million during the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive trailing twelve-month return on equity of 1.67% and a negative net margin of 11.24%.

Top institutional investors of Enhabit include Systematic Financial Management LP (3.66%), State Street Corp (2.31%), Geode Capital Management LLC (2.26%) and Jane Street Group LLC (1.79%). Insiders that own company stock include Barbara Ann Jacobsmeyer, Jeffrey Bolton, Ronald Leroy Langham Jr, L Edward Shaw Jr, Erin Hoeflinger, Charles M Elson, John E D D S Maupin Jr, Gregory S Rush, Leo I Higdon Jr and Tanya Renee Marion.
View institutional ownership trends
.

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enhabit investors own include Alphabet (GOOG), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Home Depot (HD) and Meta Platforms (META).

Company Calendar

Last Earnings
11/06/2024
Today
11/16/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/05/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
Healthcare
Fax
N/A
Employees
10,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.35
High Stock Price Target
$12.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+27.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Net Income
$-80,500,000.00
Pretax Margin
-11.00%

Debt

Sales & Book Value

Annual Sales
$1.04 billion
Cash Flow
$2.51 per share
Book Value
$11.79 per share

Miscellaneous

Free Float
49,329,000
Market Cap
$369.59 million
Optionable
Optionable
Beta
1.84
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:EHAB) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners